MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
481.79%
Quick Ratio
481.79%
Cash Ratio
65.87%
Debt to Asset Ratio
33.29%
Unit: Thousand (K) dollars
Assets Breakdown
    • Marketable debt securities, avai...
    • Operating leaseright-of-useasset...
    • Cash and cash equivalents
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Accrued expenses
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
24,783
31,930
35,995
39,072
Marketable debt securities, available-for-sale
149,825
179,828
209,898
239,219
Marketable equity securities
-
-
0
2,406
Contracts receivable
-
-
0
0
Prepaid expenses and other current assets
6,671
6,338
7,298
7,605
Total current assets
181,279
218,096
253,191
288,302
Property and equipment, net
2,500
2,653
2,770
2,927
Operating leaseright-of-useassets
24,795
25,595
26,271
30,188
Prepaid expenses and other assets
4,129
4,095
4,108
3,206
Restricted cash
2,627
2,627
2,627
2,627
Total assets
215,330
253,066
288,967
327,250
Accounts payable
8,142
7,378
7,208
7,031
Accrued expenses
29,484
27,858
29,351
30,137
Total current liabilities
37,626
35,236
36,559
37,168
Long-term lease liability
33,558
34,650
35,704
36,708
Other long-term liabilities
500
500
500
500
Total liabilities
71,684
70,386
72,763
74,376
Common stock, 0.001 par value 250,000,000 shares authorized 71,668,568 and 69,085,980 shares issued and outstanding at june30, 2026 and december31, 2025, respectively
72
71
69
72
Additional paid-in capital
1,412,745
1,409,466
1,407,394
1,408,855
Accumulated other comprehensive (loss) income
-78
-50
196
186
Accumulated deficit
-1,269,093
-1,226,807
-1,191,455
-1,156,239
Total stockholders equity
143,646
182,680
216,204
252,874
Total liabilities and stockholders equity
215,330
253,066
288,967
327,250
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Marketable debtsecurities,...$149,825K (-39.84%↓ Y/Y)Cash and cashequivalents$24,783K (-34.09%↓ Y/Y)Prepaid expenses andother current assets$6,671K (-18.30%↓ Y/Y)Total current assets$181,279K (-41.82%↓ Y/Y)Operatingleaseright-of-useassets$24,795K (-20.47%↓ Y/Y)Prepaid expenses andother assets$4,129K (28.15%↑ Y/Y)Restricted cash$2,627K (0.00%↑ Y/Y)Property and equipment,net$2,500K (-19.02%↓ Y/Y)Total assets$215,330K (-38.78%↓ Y/Y)Total liabilities andstockholders equity$215,330K (-38.78%↓ Y/Y)Total stockholdersequity$143,646K (-47.67%↓ Y/Y)Total liabilities$71,684K (-7.16%↓ Y/Y)Accumulated deficit-$1,269,093K (-12.35%↓ Y/Y)Accumulated othercomprehensive (loss) income-$78K (-232.20%↓ Y/Y)Additional paid-in capital$1,412,745K (0.63%↑ Y/Y)Total currentliabilities$37,626K (-3.58%↓ Y/Y)Long-term lease liability$33,558K (-10.96%↓ Y/Y)Other long-termliabilities$500K (0.00%↑ Y/Y)Common stock, 0.001 parvalue 250,000,000...$72K (0.00%↑ Y/Y)Accrued expenses$29,484K (-16.48%↓ Y/Y)Accounts payable$8,142K (118.93%↑ Y/Y)

Zentalis Pharmaceuticals, Inc. (ZNTL)

Zentalis Pharmaceuticals, Inc. (ZNTL)